Tuesday, November 10, 2015: 8:55 AM
155F (Salt Palace Convention Center)
Industry needs, patent expirations of ligand design and market dynamics have accelerated the development and availability of many protein affinity resins. Technology providers must consider a range of design parameters such as resin backbone, bead size, pore size, surface chemistry modification, ligand construct and how they relate to performance criteria such as DBC, life time, caustic stability, and column packing among others. Approach to designing advanced Amsphere A3(tm) affinity resin will be discussed. The trade-offs between resin design and resin performance will be illustrated through a case study. Data comparing four commercially available affinity resins with multiple monoclonal antibodies (MAb) will be discussed.
See more of this Session: Materials for the Rapid Implementation of Bioprocesses
See more of this Group/Topical: Separations Division
See more of this Group/Topical: Separations Division